Press releases, events & news from AbnomX

Discover valuable information about our platform

We are thrilled to announce the release of Antibody-Extractor 10.1, an upgrade that introduces powerful features to enhance your experience with our platform. This release comes with an advanced Antibody Items and Sequences Mining tool, offering unprecedented capabilities for querying and linking sequences to experimental...

Unlock the power of seamless antibody sequence management and experimental result linkage with Abigael, a cutting-edge, highly flexible data platform system integrated with the state-of-the-art Antibody-Extractor. Tailored for researchers, scientists, and software developers, this comprehensive solution streamlines the organization and analysis of antibody sequences, offering...

AbnomX is pleased to welcome PRECIRIX, a clinical-stage biotechnology company developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The single-domain antibody targets the cancer in minutes after IV infusion anywhere in the body. PRECIRIX will use the Antibody-Extractor™ algorithms with dedicated VHH functionality to...

AbnomX is pleased to welcome QVQ, a company providing extensive expertise in each step of lead panel VHH development, ranging from immunization, selection and screening to large scale production. QVQ will use the Antibody-Extractor™ algorithms with dedicated VHH functionality to strengthen its services to its...